CTLA-4 and Tolerance

The Biochemical Point of View

Shunsuke Chikuma, Jeffrey A. Bluestone

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Potentially autoreactive T cells that escape negative selection in the thymus must be strictly controlled in the periphery to avoid autoimmune disease. The most robust regulatory process controlling autoreactivity is mediated by the CTLA-4-B7 pathway. The critical homeostasis mediated by CTLA-4 was proven using monoclonal antibodies and genetically disrupted CTLA-4 knockout mice that develop polyclonal lymphocyte activation and proliferation leading to massively enlarged lymph nodes and spleen and fatal multiorgan lymphocytic infiltrates. CTLA-4 ligation following T-cell activation downregulates cytokine production and cell-cycle progression, however, the proximal biochemical basis for robust T-cell regulation remains unclear. In this review, we summarize studies supporting a dynamic role for CTLA-4 at the immunological synapse leading to direct attenuation of early cell signals. A model is proposed based on these observations, which proposes that CTLA-4 may, in fact, function under some circumstances in a ligand-independent manner.

Original languageEnglish
Pages (from-to)241-253
Number of pages13
JournalImmunologic Research
Volume28
Issue number3
DOIs
Publication statusPublished - 2003
Externally publishedYes

Fingerprint

T-Lymphocytes
Immunological Synapses
Lymphocyte Activation
Knockout Mice
Thymus Gland
Autoimmune Diseases
Ligation
Cell Cycle
Homeostasis
Down-Regulation
Spleen
Lymph Nodes
Monoclonal Antibodies
Cytokines
Ligands

Keywords

  • Costimulation
  • CTLA-4
  • Lipid rafts
  • Tolerance

ASJC Scopus subject areas

  • Immunology

Cite this

CTLA-4 and Tolerance : The Biochemical Point of View. / Chikuma, Shunsuke; Bluestone, Jeffrey A.

In: Immunologic Research, Vol. 28, No. 3, 2003, p. 241-253.

Research output: Contribution to journalArticle

Chikuma, Shunsuke ; Bluestone, Jeffrey A. / CTLA-4 and Tolerance : The Biochemical Point of View. In: Immunologic Research. 2003 ; Vol. 28, No. 3. pp. 241-253.
@article{40dba59b22c84559bfffd493bfc1c620,
title = "CTLA-4 and Tolerance: The Biochemical Point of View",
abstract = "Potentially autoreactive T cells that escape negative selection in the thymus must be strictly controlled in the periphery to avoid autoimmune disease. The most robust regulatory process controlling autoreactivity is mediated by the CTLA-4-B7 pathway. The critical homeostasis mediated by CTLA-4 was proven using monoclonal antibodies and genetically disrupted CTLA-4 knockout mice that develop polyclonal lymphocyte activation and proliferation leading to massively enlarged lymph nodes and spleen and fatal multiorgan lymphocytic infiltrates. CTLA-4 ligation following T-cell activation downregulates cytokine production and cell-cycle progression, however, the proximal biochemical basis for robust T-cell regulation remains unclear. In this review, we summarize studies supporting a dynamic role for CTLA-4 at the immunological synapse leading to direct attenuation of early cell signals. A model is proposed based on these observations, which proposes that CTLA-4 may, in fact, function under some circumstances in a ligand-independent manner.",
keywords = "Costimulation, CTLA-4, Lipid rafts, Tolerance",
author = "Shunsuke Chikuma and Bluestone, {Jeffrey A.}",
year = "2003",
doi = "10.1385/IR:28:3:241",
language = "English",
volume = "28",
pages = "241--253",
journal = "Immunologic Research",
issn = "0257-277X",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - CTLA-4 and Tolerance

T2 - The Biochemical Point of View

AU - Chikuma, Shunsuke

AU - Bluestone, Jeffrey A.

PY - 2003

Y1 - 2003

N2 - Potentially autoreactive T cells that escape negative selection in the thymus must be strictly controlled in the periphery to avoid autoimmune disease. The most robust regulatory process controlling autoreactivity is mediated by the CTLA-4-B7 pathway. The critical homeostasis mediated by CTLA-4 was proven using monoclonal antibodies and genetically disrupted CTLA-4 knockout mice that develop polyclonal lymphocyte activation and proliferation leading to massively enlarged lymph nodes and spleen and fatal multiorgan lymphocytic infiltrates. CTLA-4 ligation following T-cell activation downregulates cytokine production and cell-cycle progression, however, the proximal biochemical basis for robust T-cell regulation remains unclear. In this review, we summarize studies supporting a dynamic role for CTLA-4 at the immunological synapse leading to direct attenuation of early cell signals. A model is proposed based on these observations, which proposes that CTLA-4 may, in fact, function under some circumstances in a ligand-independent manner.

AB - Potentially autoreactive T cells that escape negative selection in the thymus must be strictly controlled in the periphery to avoid autoimmune disease. The most robust regulatory process controlling autoreactivity is mediated by the CTLA-4-B7 pathway. The critical homeostasis mediated by CTLA-4 was proven using monoclonal antibodies and genetically disrupted CTLA-4 knockout mice that develop polyclonal lymphocyte activation and proliferation leading to massively enlarged lymph nodes and spleen and fatal multiorgan lymphocytic infiltrates. CTLA-4 ligation following T-cell activation downregulates cytokine production and cell-cycle progression, however, the proximal biochemical basis for robust T-cell regulation remains unclear. In this review, we summarize studies supporting a dynamic role for CTLA-4 at the immunological synapse leading to direct attenuation of early cell signals. A model is proposed based on these observations, which proposes that CTLA-4 may, in fact, function under some circumstances in a ligand-independent manner.

KW - Costimulation

KW - CTLA-4

KW - Lipid rafts

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=0346496097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346496097&partnerID=8YFLogxK

U2 - 10.1385/IR:28:3:241

DO - 10.1385/IR:28:3:241

M3 - Article

VL - 28

SP - 241

EP - 253

JO - Immunologic Research

JF - Immunologic Research

SN - 0257-277X

IS - 3

ER -